4//SEC Filing
DeLuca Teresa 4
Accession 0001213900-22-028974
CIK 0001690080other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:30 PM ET
Size
8.8 KB
Accession
0001213900-22-028974
Insider Transaction Report
Form 4
DeLuca Teresa
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-05-19+21,000→ 21,000 totalExercise: $1.36Exp: 2032-05-19→ Common Stock (21,000 underlying)
Holdings
- 5,000
Common Stock
- 2,500(indirect: By Trust)
Common Stock
- 2,500(indirect: By Trust)
Common Stock
- 2,500(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
- [F2]Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
- [F3]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F4]The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001685627
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:30 PM ET
- Size
- 8.8 KB